Christopher D Turner Selected Research

glembatumumab vedotin

5/2021	Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
8/2020	A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma.
1/2019	A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher D Turner Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 01/2002
6	Disease Progression 01/2021 - 01/2002
5	Brain Neoplasms (Brain Tumor) 11/2009 - 01/2002
4	Glioma (Gliomas) 04/2012 - 01/2002
3	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 03/2007
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 11/2012
2	Diarrhea 05/2021 - 07/2007
2	Neutropenia 05/2021 - 01/2002
2	Fatigue 05/2021 - 10/2017
2	Primitive Neuroectodermal Tumors (PNET) 04/2014 - 08/2006
2	Medulloblastoma 04/2014 - 01/2002
2	Ependymoma 04/2014 - 01/2002
1	Triple Negative Breast Neoplasms 05/2021
1	Exanthema (Rash) 05/2021
1	Leukopenia 05/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	medullary Thyroid cancer 01/2021
1	Uveal melanoma 08/2020
1	Melanoma (Melanoma, Malignant) 01/2019
1	Headache (Headaches) 10/2017
1	Pulmonary Embolism 10/2017
1	Thrombocytopenia (Thrombopenia) 10/2017
1	Neuroblastoma 04/2014
1	Hematologic Neoplasms (Hematological Malignancy) 06/2013
1	Leukemia 11/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2012
1	Pancreatitis 11/2012
1	Philadelphia Chromosome 11/2012
1	Choroid Plexus Carcinoma 01/2008
1	Li-Fraumeni Syndrome 01/2008
1	Central Nervous System Neoplasms 07/2007
1	Edema (Dropsy) 03/2007
1	Necrosis 03/2007
1	Transverse Myelitis (Necrotizing Myelitis) 08/2006
1	Myelitis 08/2006
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2005
1	Rhabdomyosarcoma 03/2005
1	Hypersensitivity (Allergy) 10/2003
1	Astrocytoma (Pilocytic Astrocytoma) 01/2002

Drug/Important Bio-Agent (IBA)

3	glembatumumab vedotinIBA 05/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 01/2015 - 11/2012
3	ponatinibIBA 01/2015 - 11/2012
2	Immunoconjugates (Immunoconjugate)IBA 05/2021 - 01/2019
2	pralsetinibIBA 01/2021 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 08/2020 - 01/2019
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 01/2020 - 10/2017
2	epidermal growth factor receptor VIIIIBA 01/2020 - 10/2017
2	rindopepimutIBA 01/2020 - 10/2017
2	ridaforolimusIBA 07/2013 - 04/2012
1	Capecitabine (Xeloda)FDA Link 05/2021
1	cabozantinibIBA 01/2021
1	vandetanib (ZD6474)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	VaccinesIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	Codon (Codons)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2017
1	Cytochrome P-450 CYP3AIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 07/2013
1	Lipase (Acid Lipase)FDA Link 11/2012
1	Amylases FDA Link 11/2012
1	Phosphotransferases (Kinase)IBA 11/2012
1	TOR Serine-Threonine KinasesIBA 04/2012
1	laromustine (VNP40101M)IBA 02/2008
1	Alkylating AgentsIBA 02/2008
1	DNA (Deoxyribonucleic Acid)IBA 02/2008
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2008
1	Loperamide (Imodium)FDA LinkGeneric 07/2007
1	Farnesyltranstransferase (Farnesyltransferase)IBA 07/2007
1	lonafarnib (SCH 66336)IBA 07/2007
1	Thalidomide (Thalomid)FDA Link 03/2007
1	SteroidsIBA 03/2007
1	Biomarkers (Surrogate Marker)IBA 11/2005
1	Procarbazine (Matulane)FDA Link 10/2003
1	Lomustine (CCNU)FDA Link 10/2003
1	Carboplatin (JM8)FDA LinkGeneric 10/2003
1	Vincristine (Oncovin)FDA LinkGeneric 10/2003
1	Thioguanine (Tioguanine)FDA Link 10/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2002

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2002
9	Drug Therapy (Chemotherapy) 08/2020 - 01/2002
1	Immunotherapy 10/2017
1	Intradermal Injections 10/2017
1	Integrative Oncology 01/2009
1	Craniospinal Irradiation 08/2006
1	Induction Chemotherapy 08/2006
1	Drug Tapering 01/2002
1	Radiotherapy 01/2002